Details of the Drug Reposition

General Information of This Drug (ID: DMN6J18)

Drug Name
Vupanorsen   DMN6J18
Synonyms IONIS-ANGPTL3-LRx; AKCEA-ANGPTL3-LRx
Drug Type
Antisense oligonucleotide

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type 2 diabetes DISJ9M77 5A11 Phase 2 [1]
Hypertriglyceridemia DIS7SN6U 5C80.1 Phase 2 [1]
Non-alcoholic fatty liver disease DISDG1NL DB92 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03371355) Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease. U.S. National Institutes of Health.